Institutional Ownership
Kiniksa Pharmaceuticals Intl
CUSIP G52694109ORD SHS CL AQ1 2026
Institutional Holders
219
13F filers
Shares Held
42.15M
Aggregate institutional
Institutional Value
$1.93B
Q1 2026
Net New Holders
+1
35 new · 34 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions35
Increased74
Decreased84
Sold out34
Institutional Holders
219 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Fmr LLC | 6.82M | $328.56M | +5.18M | Added |
| 2 | Rubric Capital Management LP | 3.75M | $180.56M | +421.3K | Added |
| 3 | Baker Bros. Advisors LP | 2.83M | $136.08M | 0 | Held |
| 4 | Tang Capital Management LLC | 2.26M | $108.81M | 0 | Held |
| 5 | Morgan Stanley | 997.8K | $48.04M | −362.3K | Reduced |
| 6 | D. E. Shaw & Co., Inc. | 959.3K | $46.19M | −282.4K | Reduced |
| 7 | Arrowstreet Capital, Limited Partnership | 892.7K | $42.98M | −175.6K | Reduced |
| 8 | Dimensional Fund Advisors LP | 811.9K | $39.09M | +128.4K | Added |
| 9 | Spruce Street Capital LP | 761.1K | $36.65M | +326.1K | Added |
| 10 | Bank Of America Corp /De/ | 735.9K | $35.44M | +506.6K | Added |
209 more institutional holders on Premium
See every fund holding Kiniksa Pharmaceuticals Intl, with full quarter-over-quarter share changes.
Unlock all holders